Question 1

What is receptor occupancy theory?

Accepted Answer

Receptor occupancy theory, originally developed by A.J. Clark in the 1920s–30s, proposes that the magnitude of a pharmacological effect is proportional to the fraction of receptors occupied by a drug. The basic formulation is: occupancy = [D] / (KD + [D]), where [D] is the free drug concentration and KD is the equilibrium dissociation constant (the concentration at which 50% of receptors are occupied). In modern pharmacodynamics, this is equivalent to the Hill equation (or Emax model): E = (Emax × [D]^n) / (EC50^n + [D]^n), where Emax is the maximum possible effect, EC50 is the drug concentration producing 50% of maximum effect, and n is the Hill coefficient (steepness of the concentration-effect relationship). When n = 1 (simple hyperbolic), the EC50 equals the KD. The Hill coefficient n > 1 describes cooperative binding or steep dose-response curves (as seen with some ligand-gated ion channels and allosteric systems); n < 1 describes shallow curves. Receptor occupancy theory has limitations: it assumes drug effect is directly proportional to occupancy, does not account for receptor reserve (spare receptors), partial agonism, signal amplification, or time-dependent phenomena like tolerance.

Question 2

What are EC50, EC95, and Emax, and how do they guide dosing?

Accepted Answer

EC50 is the concentration producing 50% of maximal effect (Emax) — it is the primary measure of drug potency. EC95 (the concentration producing 95% of Emax) is derived from the Hill equation: EC95 = EC50 × (19)^(1/n). For n = 1, EC95 = 19 × EC50. Dosing to EC50 gives only 50% of the maximum possible effect — for drugs needing near-maximum effect (e.g., antibiotics needing minimum inhibitory concentration coverage, anticoagulants), target concentrations must be set relative to EC90 or EC95. EC50 versus IC50: for inhibitors (antagonists, enzyme inhibitors), IC50 (half-maximal inhibitory concentration) is the equivalent measure. Emax represents the intrinsic efficacy ceiling — partial agonists cannot exceed their own Emax regardless of dose. The PD index for antimicrobial therapy translates these concepts: for time-dependent antibiotics (beta-lactams), efficacy correlates with the proportion of time above the MIC (T>MIC), equivalent to maintaining concentration above the EC50 equivalent for bacterial killing. For concentration-dependent antibiotics (aminoglycosides), efficacy correlates with Cmax/MIC ratio. PK/PD modelling integrates the drug concentration-time profile with the Emax model to predict clinical outcomes.

Question 3

What is receptor reserve and how does it relate to partial agonists?

Accepted Answer

Receptor reserve (spare receptors) describes the phenomenon where maximal pharmacological response can be achieved when only a fraction of available receptors are occupied. This occurs when the signal transduction cascade downstream of the receptor is amplified — so that occupying 5–10% of receptors generates 100% of the cellular response. Evidence for receptor reserve comes from partial alkylation experiments (Furchgott, 1954): irreversible blockade of some receptors shifts the agonist concentration-response curve rightward without reducing Emax until a threshold of receptors is destroyed, after which Emax falls. In systems with large receptor reserve, the KD (affinity constant) does not equal the EC50 — EC50 < KD because less than 100% occupancy is needed for Emax. Receptor reserve magnitude varies by tissue and receptor type. Practically: receptor reserve explains why highly efficacious full agonists produce maximal effects at low receptor occupancy; partial agonists have limited intrinsic efficacy regardless of receptor reserve — they activate the receptor to a submaximal level even when all receptors are occupied. Clinically: buprenorphine (partial mu-opioid agonist) has a ceiling effect on respiratory depression (useful for safety) but also on analgesia; it competitively displaces full agonists at high doses, potentially precipitating withdrawal.

Question 4

How does the Hill equation differ from simple receptor occupancy theory?

Accepted Answer

Simple receptor occupancy theory (Clark) assumes: (1) drug-receptor interaction is bimolecular and reversible; (2) effect is directly proportional to fractional occupancy; (3) all receptors are equivalent and independent. The Hill equation extends this with the Hill coefficient n (also called the sigmoidicity factor), which accounts for cooperative binding or multiple mechanistic steps between receptor binding and observed effect. When n > 1, the response curve is steeper than a simple rectangular hyperbola — small increases in concentration near the EC50 produce disproportionately large changes in effect. Pharmacological examples of n > 1 include: nicotinic acetylcholine receptor (ligand-gated ion channel requiring two agonist molecules); haemoglobin oxygen binding (cooperative binding, n ≈ 2.8); GABA-A receptor (Hill coefficient 1.5–2.5 for some benzodiazepines in patch clamp). N > 1 is also observed as an emergent property even without true cooperative binding when multiple sequential steps exist between receptor occupancy and observed response. Operationally, fitting the Hill equation to dose-response data provides Emax, EC50, and n — these three parameters characterise the sigmoidal dose-response relationship used in PK/PD modelling and exposure-response analysis for regulatory submissions.

Receptor occupancy theory

Hill equation parameters

Frequently asked questions